Laitinen Olli H, Nordlund Henri R, Hytönen Vesa P, Kulomaa Markku S
A.I. Virtanen Institute, Department of Molecular Medicine, University of Kuopio, P.O. Box 1627, FI-70211 Kuopio, Finland.
Trends Biotechnol. 2007 Jun;25(6):269-77. doi: 10.1016/j.tibtech.2007.04.001. Epub 2007 Apr 12.
Avidin and streptavidin are widely used in (strept)avidin-biotin technology, which is based on their tight biotin-binding capability. These techniques are exceptionally diverse, ranging from simple purification and labeling methods to sophisticated drug pre-targeting and nanostructure-building approaches. Improvements in protein engineering have provided new possibilities to develop tailored protein tools. The (strept)avidin scaffold has been engineered to extend the existing range of applications and to develop new ones. Modifications to (strept)avidins--such as simple amino acid substitutions to reduce biotin binding and alter physico-chemical characters--have recently developed into more sophisticated changes, including chimeric (strept)avidins, topology rearrangements and stitching of non-natural amino acids into the active sites. In this review, we highlight the current status in genetically engineered (strept)avidins and illustrate their versatility as advanced tools in the multiple fields of modern bioscience, medicine and nanotechnology.
抗生物素蛋白和链霉抗生物素蛋白广泛应用于抗生物素蛋白-生物素技术,该技术基于它们与生物素的紧密结合能力。这些技术种类繁多,从简单的纯化和标记方法到复杂的药物预靶向和纳米结构构建方法。蛋白质工程的进步为开发定制化蛋白质工具提供了新的可能性。抗生物素蛋白支架经过工程改造,以扩展现有应用范围并开发新的应用。对抗生物素蛋白的修饰——如简单的氨基酸替换以降低生物素结合并改变物理化学性质——最近已发展为更复杂的变化,包括嵌合抗生物素蛋白、拓扑重排以及将非天然氨基酸拼接至活性位点。在本综述中,我们强调了基因工程抗生物素蛋白的当前状况,并展示了它们作为现代生物科学、医学和纳米技术多个领域的先进工具的多功能性。